Vault-13

Healthcare Value Capital, LLC

Woodcliff Lake, NJ · CIK 1458461 · 13F filing filed 2021-11-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$38.5m reported value -16.7% vs Q2 2021
18positions
80.9%in top 10
2 new 3 added 4 reduced 2 sold out vs Q2 2021

Options: 5 call positions ($6.9m notional), 2 put positions ($5.2m notional) – listed below, not included above.

Holdings, Q3 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GILEAD SCIENCES INC COM GILD GILD 60,000 $4.2m10.88% 10.88% ReducedShares held: Q4 2020 50.0k, Q1 2021 75.0k, Q2 2021 75.0k, Q3 2021 60.0k -15.0k -15,000 -20.0%
2 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 100,000 $3.8m9.92% 9.92% UnchangedShares held: Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k, Q3 2021 100.0k
3 PFIZER INC COM PFE PFE 75,000 $3.2m8.37% 8.37% ReducedShares held: Q4 2020 0, Q1 2021 100.0k, Q2 2021 100.0k, Q3 2021 75.0k -25.0k -25,000 -25.0%
4 ALKERMES PLC SHS ALKS ALKS 100,000 $3.1m8.00% 8.00% ReducedShares held: Q4 2020 0, Q1 2021 100.0k, Q2 2021 150.0k, Q3 2021 100.0k -50.0k -50,000 -33.3%
5 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 250,000 $3.0m7.85% 7.85% AddedShares held: Q4 2020 0, Q1 2021 155.6k, Q2 2021 200.0k, Q3 2021 250.0k +50.0k +50,000 25.0%
6 MERCK & CO INC COM MRK MRK 40,000 $3.0m7.80% 7.80% UnchangedShares held: Q4 2020 0, Q1 2021 20.0k, Q2 2021 40.0k, Q3 2021 40.0k
7 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 50,000 $3.0m7.79% 7.79% UnchangedShares held: Q4 2020 0, Q1 2021 25.0k, Q2 2021 50.0k, Q3 2021 50.0k
8 BRISTOL-MYERS SQUIBB CO COM BMY BMY 50,000 $3.0m7.68% 7.68% UnchangedShares held: Q4 2020 0, Q1 2021 25.0k, Q2 2021 50.0k, Q3 2021 50.0k
9 IRONWOOD PHARMACEUTICALS INC COM CL A IRWD IRWD 200,000 $2.6m6.78% 6.78% UnchangedShares held: Q4 2020 0, Q1 2021 200.0k, Q2 2021 200.0k, Q3 2021 200.0k
10 CLOVIS ONCOLOGY INC COM CLVS CLVS 500,000 $2.2m5.79% 5.79% UnchangedShares held: Q4 2020 250.0k, Q1 2021 450.0k, Q2 2021 500.0k, Q3 2021 500.0k
11 TYME TECHNOLOGIES INC COM TYME TYME 2,000,000 $2.1m5.35% 5.35% AddedShares held: Q4 2020 2.2m, Q1 2021 1.5m, Q2 2021 1.5m, Q3 2021 2.0m +500.0k +500,000 33.3%
12 ANTARES PHARMA INC COM ATRS ATRS 500,000 $1.8m4.72% 4.72% UnchangedShares held: Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 500.0k, Q3 2021 500.0k
13 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 5,000 $907.0k2.35% 2.35% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 5.0k
14 GREENLANE HLDGS INC CL A CL A 350,000 $830.0k2.15% 2.15% UnchangedShares held: Q4 2020 250.0k, Q1 2021 250.0k, Q2 2021 350.0k, Q3 2021 350.0k
15 VYNE THERAPEUTICS INC COM COM 400,000 $556.0k1.44% 1.44% ReducedShares held: Q4 2020 0, Q1 2021 400.0k, Q2 2021 450.0k, Q3 2021 400.0k -50.0k -50,000 -11.1%
16 ADAMAS PHARMACEUTICALS INC COM ADMS ADMS 100,000 $491.0k1.27% 1.27% UnchangedShares held: Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k, Q3 2021 100.0k
17 GAMIDA CELL LTD SHS SHS 100,000 $392.0k1.02% 1.02% AddedShares held: Q4 2020 50.0k, Q1 2021 50.0k, Q2 2021 75.0k, Q3 2021 100.0k +25.0k +25,000 33.3%
18 DURECT CORP COM DRRX DRRX 250,000 $320.0k0.83% 0.83% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 250.0k

Sold out since Q2 2021

SecurityTickerShares held beforeValue then
COLLEGIUM PHARMACEUTICAL INC COLL COLL 100,000 $2.4m100.0k shares
MIMEDX GROUP INC MDXG MDXG 125,000 $1.6m125.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ALKERMES PLC ALKS · Put ALKSPut 100,000 $3.1m100.0k shares New
PROSHARES TR Call Call 150,000 $2.6m150.0k shares Added
PFIZER INC PFE · Put PFEPut 50,000 $2.2m50.0k shares New
PROSHARES TR Call Call 200,000 $1.7m200.0k shares Added
PROSHARES TR II Call Call 50,000 $1.2m50.0k shares New
AMARIN CORP PLC Call Call 200,000 $1.0m200.0k shares Unchanged
PROSHARES TR II Call Call 12,500 $285.0k12.5k shares Reduced